Home Approval

Approval

Dr. Reddy’s Laboratories announces entering into a definitive agreement to sell its neurology branded...

Hyderabad, June 14, 2019: Dr. Reddy's Laboratories Limited (BSE: 500124, NSE: DRREDDY, NYSE: RDY), announces that it has entered into a definitive asset purchase agreement with Upsher-Smith Laboratories, LLC (Upsher-Smith), pursuant to which Dr. Reddy's would sell its US...